TP53 Status and Response to Chemotherapy in Breast Cancer

Publisher： Karger

E-ISSN： 1423-0291|75|2|132-139

ISSN： 1015-2008

Source： Pathobiology, Vol.75, Iss.2, 2008-06, pp. : 132-139

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

TP53 Codon 72 and Intron 3 Polymorphisms and Mutational Status in Gastric Cancer: An Association with Tumor Onset and Prognosis

By  

Pathobiology, Vol. 79, Iss. 6, 2012-06 ,pp. : 323-328

Karger

Access to resources Recommend Favorite

Radiological and Pathological Predictors of Response to Neoadjuvant Chemotherapy in Breast Cancer: A Brief Literature Review

By  

Pathobiology, Vol. 82, Iss. 3-4, 2015-08 ,pp. : 124-132

Karger

Access to resources Recommend Favorite

Future Perspectives for the Development of Chemotherapy for Advanced Gastric Cancer: Japanese and Global Status

By  

Pathobiology, Vol. 78, Iss. 6, 2011-11 ,pp. : 334-342

Karger

Access to resources Recommend Favorite

Effect of Cytotoxic Chemotherapy on Serum Lipid Levels in Breast Cancer Patients

By  

Pathobiology, Vol. 67, Iss. 3, 1999-06 ,pp. : 129-132

Karger

Access to resources Recommend Favorite

Expression of RUNX3 Gene, Methylation Status and Clinicopathological Significance in Breast Cancer and Breast Cancer Cell Lines

By  

Pathobiology, Vol. 75, Iss. 4, 2008-06 ,pp. : 244-251

Karger

Access to resources Recommend Favorite